Introduction
The collagen family currently includes at least 24 members (1, 2) , and four different collagen-binding integrins α1β1, α2β1, α10β1 (3) and α11β1 (4) are known. The α3β1 integrin does not interact directly with collagen, but act as a laminin receptor (5) that can affect the activity of the collagen receptor α2β1 through receptor cross-talk (6) . α1β1, α2β1, α10β1 and α11β1 each possess an inserted, or I-, domain closely related to the von Willebrand factor A domain, which mediates binding to native collagens. In different in vitro assays, αvβ3 also appears to be able to interact with type I collagen (7) (8) (9) . However, this interaction most likely involves RGD motifs in denatured or partially unfolded collagen chains.
Studies of collagen-binding integrins in various in vitro assays show that they take part in cell adhesion, cell migration, control of collagen synthesis, matrix metalloproteinase (MMP) synthesis, remodeling of collagen matrices, and influence such complex processes as cell proliferation, cell differentiation, angiogenesis, platelet adhesion/aggregation and epithelial tubulogenesis (10, 11) .
Using transfected cells and recombinant I domain, α1β1 has been shown to bind collagens, with a preference for collagens IV and VI over collagen I and 4 with this, when the α1 integrin chain is expressed in K562 cells, α1β1 will bind type IV collagen, but it requires activation in order to bind laminin-1 (18) . In CHO cells, α1β1 integrin does not mediate spreading on collagen II (12) . It has been suggested that in CHO cells a co-receptor is needed for α1β1-mediated spreading on collagen II.
Integrin α2β1 and its α I domain have been shown to bind a variety of collagens (19) (20) (21) , the C-propeptide of collagen I (16, 22) , laminin-1 (23), laminin-2 (14), decorin (24) and the cartilage protein chondroadherin (25) .
Unlike the other ligands for α1β1 and α2β1, chondroadherin does not support cell spreading. Early studies using antibodies showed that α2β1 on some cells (melanoma LOX cells), but not others (fibroblasts, platelets), mediated the binding to laminin-1 (26) .
The integrin subunit α10 was originally identified by affinity purification of collagen type II-binding integrins from adult chondrocytes (3) . The rather restricted expression of α10β1 to cartilage indicates that the ligands are to be found in the cartilage extracellular matrix. Intriguingly, using recombinant protein, the collagen-binding preference of the α10 I domain is most similar to that of the α1 I domain, so that the α10 I domain prefers the basement membrane collagen IV and the beaded-filament forming collagen VI over the interstitial collagens I and II (27). In the same study, mutational analysis of the I domains showed that the amino acid residue R218 in α1 and α10 and D219 in α2 are involved in determining this collagen preference.
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protein and mRNA expression analysis in human embryos, however, reveal that expression is localised to mesenchymal non-muscle cells in areas of highly organized interstitial collagen networks. No expression was seen in muscle cells in vivo (29) . In the developing skeletal system, α10β1 and α11β1 thus show non-overlapping, complementary expression patterns (11) . In accordance with the expression of α11β1 in areas rich in interstitial collagens, α11β1 binds more efficiently to collagen I than to collagen IV (29) .
Cyanogen bromide cleavage of collagen chains identified the non-RGDcontaining helical CB3 fragment of collagen α1(I) as a cell-binding fragment which could be used to purify α1β1 (30) . The α1 I and α2 I integrin binding site located within triple-helical α1(I) CB3 has been identified as GFOGER (31, 32) . Two related sequences, GLOGER and GASGER, were identified elsewhere in collagen I (33) and other GER-containing sequences in the collagen chains can also mediate cell adhesion through α2β1 (Farndale et al, in preparation). The GER motif thus appears to be a major cell adhesion motif used by collagen-binding integrins.
Examination of the crystal structure of an α2 I domain-GFOGER complex suggested that other hydrophobic residues might substitute for phenylalanine (F), which together with the glutamate (E) and arginine (R) residues provided the main side-chain interactions between the collagen-like peptide and the integrin (34) . Interactions also occurred with the main-chain carbonyl group of the hydroxyproline (O) residue, suggesting that O itself may not be required specifically for collagen-integrin interaction.
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Residue R interacts with negatively-charged D219 on the surface of the α2 Idomain, and although this appears a relatively non-specific interaction, GEK will not substitute in human platelets. The ligand binding groove of the α2 Idomain is relatively deep compared with that of α1. Thus, the coordination of Mg 2+ in the metal ion dependent adhesion site (MIDAS) may only be achieved by E residues from the GER motif, D being too short for this purpose. This may not be the case for other integrins, and the abundance of GDR triplets within the collagens suggests the possibility that GDR motifs might serve as well. The present study was designed in part to test the possibility that α11, which lacks an acidic residue equivalent to D219, and whose structure is not yet defined, might recognise GEK and GDR triplets, both of which occur frequently in human collagens.
Other modes of collagen binding also exist, and α1β1 bind to collagen type IV using the amino acids R and D contributed from different collagen alpha chains (35, 36) . The residues recognized by α1β1 in collagen XIII, lacking a GFOGER sequence, have not been identified. Studies with fragments of laminins have shown that the I domain integrin binding sites are present in the short arm of the α-chain, but the exact region(s) has not yet been mapped (13, 14 In the present study we set out to further study the mechanism whereby α2β1 and α11β1 integrins bind collagens. Our data suggest that the approximated Kd of α11 I domain for type I collagen is higher than that of α2 I domain and that in C2C112 cells the α11β1-mediated binding to collagen I, but not that of α2β1, is sensitive to the presence of Ca 2+ . However, both integrins display a similar collagen specificity and both recognize the helical GFOGER sequence.
Modeling of α2 I and α11 I domain-ligand complexes could in part explain the observed differences in α2 I and α11 I domain binding to different collagen peptides. The results are potentially promising for future attempts to generate 8 reagents effective in blocking multiple collagen-binding integrins simultaneously.
Materials and Methods
Production of human recombinant integrin α1 I, α2 I, and a11 I domains as fusion protein cDNAs encoding α1 I and α2 I domains were generated by PCR as described earlier (27) using human integrin α1 and α2 cDNAs as templates. Vectors pGEX-4T-3 and pGEX-2T (Pharmacia) were used to generate recombinant glutathione S-transferase (GST) fusion proteins of human α1 I and α2 I domains, respectively. Human integrin α11 cDNA (4) was used as a template when α11 I domain was generated by PCR. PCR product having BamHI and
EcoRI sites was cloned to pGEX-KT and the DNA sequence was checked by sequencing the whole insert. The same vector was used for expression of recombinant GST fusion proteins of human α11 I domain. Competent E. coli BL21 cells were transformed with the plasmids for protein production. 500 ml LB medium (Biokar) containing 100 µg/ml ampicillin was innoculated with 50 ml overnight culture of BL21/pα1I, BL21/pα2I or BL21/p α11I and the cultures were grown at 37°C until the O.D. 600 of the suspension reached 0.6-1.0. Cells were induced with IPTG and allowed to grow for an additional 4-6 h before harvesting by centrifugation. Pelleted cells were resuspended in PBS (pH 7.4), then lysed by sonication followed by addition of Triton X-100 to a final concentration of 2%. After incubation for 30 min on ice, suspensions were centrifuged, and supernatants were pooled. Glutathione Sepharose (Pharmacia) was added to the lysate, which was incubated at room temperature for 30 min with gentle agitation. The lysate was then centrifuged, the supernatant was removed, and Glutathione Sepharose with bound fusion protein was transferred into disposable chromatography columns (Bio-Rad).
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The columns were washed with PBS, and fusion proteins were eluted using 30 mM glutathione. Purified recombinant and glutathione-tagged α1 I, α2 I, and α11 I domains were analysed by SDS and native polyacrylamide gel electrophoresis (PAGE). The recombinant α1 I domain produced was 227 amino acids in length, corresponding to amino acids 123-338 of the whole α1 integrin, while the α2 I domain was 223 amino acids long which corresponded to amino acids 124-339 of the whole α2 integrin. The carboxyl termini of the α1 I and α2 I domains contained ten and six non-integrin amino acids, respectively. Recombinant α11 I domain contains a total of 204 amino acids: at the amino terminus there are two extra residues (GS) before the α11 I domain, which starts from CQTY and ends with SLEG (residues 159-354); at the carboxyl terminus there are six extra amino acids (EFIVTD). Recombinant α11 I domain contains some GST as an impurity due to endogenous protease activity during expression and purification. Recombinant I domains were used as GST-fusion proteins for collagen binding experiments.
Synthesis of peptides
Peptides were synthesized as C-terminal amides on TentaGel R RAM resin in a PerSeptive Biosystems 9050 Plus Pep-Synthesizer exactly as described in our earlier studies (30, 31) . Peptides were purified by reverse-phase high performance liquid chromatography on a column of Vydac 219TP101522 
Antibodies
Rabbit antibodies to the cytoplasmic tail of α11 integrin have been described previously (4). To immunoprecipitate β1 integrins, a polyclonal antibody to rat integrin β1 chain was used (38) .
Immunoprecipitation and electrophoresis
Cell 
Cell attachment assay
General setup (ligands and metal ions are described separately for the two experiments):
24-well cell culture plates (Nunc) were coated with ligands (500 µl to a 2 cm 2 well) diluted in PBS over night at 4°C, followed by blocking with 2% BSA in PBS for 2 h at room temperature and then washed in Puck's saline (137 mM NaCl, 5 mM KCl, 4 mM Na 2 CO 3 , 5.5 mM D-glucose, pH 7.0 ). Transfected cells were trypsinized and washed four times in Puck's saline, and seeded into the wells at a concentration of 250,000 cells/well, and were allowed to attach for 45 min at 37°C and 5% CO 2 . Wells were washed three times in Puck's saline and plates were rapidly frozen at -20°C for later assay using the hexoseaminidase test as described previously (29) . For each cell line used, a cell number standard was made. Each experiment was performed in triplicates. In order to minimize errors from unequal trypsinization stress between cell lines and handling of plates etc., data was normalized as follows:
For each plate the adhesion to fibronectin (10 µg/ml, provided by S.
Johansson, Uppsala University) was used as the 100% reference level and the Cell attachment to synthetic peptides:
24-well plates were coated with synthetic triple-helical collagen peptides(10 µg/ml at +4°C overnight) according to figure 4 , or bovine collagen type I (Vitrogen®100, Cohesion, USA) (10 µg/ml), or fibronectin (10 µg/ml). MgCl 2 and CaCl 2 was added to a final concentration of 2 mM MgCl 2 , and 0.01 mM CaCl 2 .
Homology modeling
Sequences of integrin α1 (accession code: P56199; (39)) and α11 (Q9UKX5; Homology models were built with HOMODGE in BODIL. The amino acid side chain rotamer library incorporated into BODIL was used to evaluate alternative possibilities for side chain conformations for sequence differences in the alignment of α1 and α11 I domain sequences with the template structure.
In the α2 I domain -peptide complex structure, 1dzi, the three peptide chains 
Results
Influence of Ca 2+ on cell attachment to collagen
To compare the mechanism whereby α11β1 and α2β1 recognize collagens, we used the satellite cell line C2C12 transfected with α2 or α11 cDNAs (C2C12 α2+ and C2C12 α11+, respectively). The parental cell line C2C12 expresses members of the β1 subfamily, such as α5β1 and α7β1 (45) but does not adhere to collagen (29) . C2C12 cells transfected with either α2 or α 11 acquire the ability to interact with collagens I and IV, with a preference for collagen I (29).
The α2β1-mediated binding of platelets to collagen has been reported to require micromolar Ca 
Collagen preference of α11 I domain
Previous studies from several laboratories have shown that α2β1 integrin prefers fibril-forming collagens over network-forming type IV and beadedfilaments forming type VI collagen. The same pattern can be seen in the binding of α2 I domain. Here α 2-and α11-mediated binding to different collagens was compared. α11 I domain was shown to prefer the fibril-forming collagen types I and II (Figure 3) , whereas its binding was weaker to type III (data not shown), a member of the same collagen subgroup. Collagens IV and VI were poor ligands for α11 I domain. Thus, in the terms of its binding pattern the α11 I domain was closer to the α2 I domain than to either the α1 or α10 I domains.
Binding to GER-containing peptides
Helical GFOGER and GFOGER-like peptides have recently been shown to by guest on January 8, 2018
http://www.jbc.org/ Downloaded from represent high affinity integrin recognition motifs in collagens (32, 33) . To determine whether α11β1 also differed from α2β 1 with regard to its recognition sequences, C2C12 α2+ and C2C12 α11+ cells were tested for their ability to attach to different collagen-like peptides. C2C12 α2+ cells adhered to GFOGER and GFOGEK peptides as previously reported. C2C12 α11+ cells also bound these peptides in a similar pattern, whereas untransfected cells failed to do so (Figure 4) .
To confirm that the observed binding occurred via the αI domain, I domains from α1, α2, and α11 were compared with regard to binding to the different collagen-derived peptides ( Figure 5 ). In these studies we also included the GLOGER peptide (33) which bound all I domains. The α11 I domain preferred the GFOGER peptide followed by the GFOGEK and GLOGER peptides, much like the α2 I domain. The α1 I domain bound the GLOGER peptide as efficiently as the GFOGER peptide. The peptide containing the sequence GASGER, reported as a weak binding site for α2β1 and α1β1
showed only low capacity to bind any of the I domains, and substitution of D for E within the GER triplet similarly abolished I domain binding. The sequence GPOGES, from the collagen I α2 chain where it corresponds to GFOGER in the α1(I) chain, was similarly without significant binding activity.
Comparing the overall peptide-binding pattern, α2 I and α11 I domains appear most similar in their peptide binding preferences.
Modeling of collagen peptide binding to the α11 I domain
The basic assumption in modeling was that the collagen mimetic tri-peptide
GFOGER and its mutants bind to all of the integrin α I domains in a similar
http://www.jbc.org/ Downloaded from way as is seen in the crystal structure of the complex between α2 I domain and the GFOGER triple helical peptide (PDB-code: 1dzi; (34)). The sequence identity of the α1 and α11 I domains to the α2 I domain are 51% and 45%
respectively, thus experience dictates that high quality models will be produced. Only one region of the α11 I domain model is uncertain, where P310 (threonine in the α1 and α2 I domains) is located within a region that corresponds to helix-6 of the open-fold of the α1 and α2 I domains. A proline residue generally does not promote helix stability so it is very likely that the helix begins at or after position 310 in the α11 I domain. In addition, the local alignment of residues 179 and 180 seems peculiar, since the charged residue E180 would be buried and the hydrophobic residue V179 would be exposed towards the solvent. If E180 is buried, then the conserved residue Y157 may change its conformation in the α11 I domain and affect the binding of the collagen mimetic tri-peptide. Thus, it is possible that the binding conformation seen in α2 I domain-tri-peptide complex structure may be different in the case of α11.
Glutamate in the collagen mimetic tri-peptide
In the crystal structure of the integrin α2 I domain in complex with the collagen mimetic peptide (3 x GFOGER), the side chain of only one of the glutamate residues in the collagen mimetic tri-peptide, that of the middle strand, chain C, interacts with the I domain. This glutamate is coordinated to the metal-ion of the MIDAS motif and thus, represents a key interaction in tripeptide binding (Figure 6) . Moreover, even a conservative change, mutation to aspartate, lowers the binding dramatically for the α1 I, α 2 I and α11 I domains (GFOGDR; Figure 4) . Aspartate is one methylene group shorter than 20 glutamate and would not reach the metal-ion of the MIDAS motif as easily as glutamate can.
In the α2 I domain there is a leucine residue at position 286, which forms an interaction with phenylalanine of the collagen mimetic tri-peptide from chain B, whereas, both the α1 and α11 I domains have tyrosine at that position.
Tyrosine could either form a hydrophobic interaction with a planar face of the R148 side chain, or tyrosine could form a hydrogen bond with glutamate from the collagen mimetic tri-peptide chain B. If the latter case is true then the hydrogen bond would not be possible in the collagen mimetic tri-peptide containing the E D mutation.
In the α1 I domain model, R218 (aspartate in α2 and threonine in α11) may form an additional interaction with the glutamate of chain D of the collagen mimetic tri-peptide. This interaction would still be possible in the tri-peptide containing the aspartate mutation.
Arginine in the collagen mimetic tri-peptide
In the crystal structure of the α2 I domain (1dzi), arginine in chain C of the collagen mimetic tri-peptide is bound to the area where D219, N189 and L220 are located. The Nε and Nη2 atoms of arginine would interact with side chain carboxylate of D219 but only weakly since the angle is not optimal for forming a strong hydrogen-bond/salt bridge. In addition, the side chain of L220 forms an optimal site for hydrophobic interactions with a planar face of the arginine side chain ( Figure 6A) . In both α1 and α11, arginine of the tripeptide could form a salt bridge with glutamate at the position equivalent to 21 N189 in α2 (Figure 6B,C) . Furthermore, in α11 there is a threonine equivalent to D219 in α2 whose side chain hydroxyl group can accept a hydrogen bond from the Nε of arginine from the tri-peptide ( Figure 6C ). For α2, the mutation of arginine to lysine in the collagen mimetic tri-peptide (GFOGEK) does not affect binding as dramatically as seen for α1 and α11 (Figure 5) . In α2, the repulsion resulting from the charged amino group of lysine positioned near the L220 side chain would be offset by the formation of a somewhat more optimal hydrogen bond/salt bridge between lysine and D219 ( Figure 6D ).
The mutation of arginine to lysine reduces the binding affinity of collagen mimetic tri-peptide to α1 and α 11 I domains, because the salt bridge to glutamate, at the position equivalent to N189 in α2, cannot be maintained.
When arginine of the collagen mimetic tri-peptide is mutated to lysine, lysine cannot reach glutamate because a lysine residue is shorter than an arginine residue. Moreover, in α11 the lysine residue can form a hydrogen bond with the threonine equivalent to D219 in α2, and thus, the effect of the mutation is not as dramatic as for α1.
In the α2 I domain, the arginine from chain B of the collagen mimetic tripeptide interacts mainly with other parts of the tri-peptide and not with the I domain. Nε is hydrogen bonded to the main-chain oxygen of arginine in chain C and the planar end of the arginine side chain has a hydrophobic interaction with proline in peptide chain C. In addition, hydrophobic interactions with the hydrophobic part of the E256 side chain and weak electrostatic interactions with the main-chain oxygen atom of S257 can be seen. These interactions should be present and identical in each of the I 22 domains in this study. Thus, the effect of the mutation of arginine to lysine, due to chain C, should be same for all I domains.
In the α2 structure, the arginine from chain D of the collagen mimetic tripeptide is exposed to the solvent and, thus, the mutation can only have an indirect influence on I domain binding.
Phenylalanine in the collagen mimetic tri-peptide
In the α2 I domain structure, the phenyl ring of phenylalanine in chain B of the collagen mimetic tri-peptide is stacked with the phenol ring of the conserved tyrosine (position 157 in α2). This phenylalanine also has hydrophobic interactions with L286 in α2. In addition, the phenylalanine of chain B forms an unfavourable interaction with the main-chain oxygen atom of Y285 ( Figure 7A) . A corresponding view of phenylalanine interactions with the α1 I domain is shown in figure 7B .
When phenylalanine of the collagen mimetic tri-peptide is mutated to leucine, some favourable interactions would be lost, but this loss is offset by the removal of unfavourable interactions with the main-chain oxygen atom of the residue at position 285 (tyrosine in α2 and α11; serine in α1). Thus, there is a small change in the binding affinity of α1 and α2 when the F L mutant is compared with the "wild type" tri-peptide ( Figure 5) . The effects seen for α11 are difficult to predict because the model is inaccurate in this region. The binding affinity is dramatically lowered when phenylalanine is replaced with alanine resulting in the loss of all favourable interactions ( Figure 5 ).
Discussion
In recent years an increasing effort has been spent trying to understand the mechanism whereby cells bind collagen. In vertebrates more than 24 different collagens exist, and the role of some of these is yet unclear. Integrins are major receptors for collagens. A common feature of the collagen-binding integrins is the presence of an α I domain which is directly involved in ligand binding.
The I domain is not found in integrin α chains from the invertebrate Drosophila melanogaster but it is present in 9 of the 18 currently known vertebrate integrin α chains (11) including αL, αM, αX , αD, and αE which are all involved in different aspects of leukocyte functions and pair exclusively with the β2 subunit (10). The overall importance of integrinmediated cell-collagen interactions involving the α1, α2, α10 and α11 integrin chains is largely unknown due to the limited information available for α10β1 and α11β1. Based on the appearance of I domain integrin α-chains during vertebrate evolution it is possible that these integrin chains play important roles in vertebrate-specific structures of the musculoskeletal system.
Gene knockout experiments and recombinant expression of the αI domains have yielded considerable information about the characteristics and functions of collagen-binding integrin α1β1 and α2β1 (11, 46, 47) . Phylogenetically, α1
and α2 form a subfamily distinct from α10 and α11, which most likely have formed through two distinct gene duplication events. Studies of α1 I, α2 I and α10 I domains have shown that they bind collagens with different specificity (27). This specificity seems in part to be determined by residues located outside the MIDAS motif in the α I domain. Data from several groups have convincingly shown that α1 prefers collagens IV and VI over collagen I, and that preferences of α2 are opposite. More recently the α10 I domain was shown to display a collagen-binding specificity similar to α1 (27).
Prior to this study no binding studies had been performed with the α11 I domain. It thus appears that although α1 is, in terms of evolution, more 26 similar to α2, and α10 is more closely related to α11, another grouping can be made based on their collagen specificity. The finding that α11 I prefers interstitial collagens over non-fibrillar collagens supports our previous cell binding data (29) , but the difference is even more pronounced at the I domain level. A candidate amino acid that might play a role in determining this preference is T238 found in a position corresponding to R218 in α1.
The relatively low avidity for collagens estimated for both α1 0 I and α1 1 I domains are intriguing. Our experience is that as recombinant GST fusion proteins, these I domains are less soluble than α1 I and α2 I domains The α2β1-mediated binding of platelets to collagen I is inhibited by mM concentrations of Ca 2+ (37 varies.
Despite the differences in collagen specificity, helical GFOGER-like sequences are recognized by α1β1, α2β1 and as shown in this study, also by α11β1. . Adhesion was measured as described in Materials and Methods. 
